Detalles de la búsqueda
1.
A direct healthcare cost analysis of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol.
Arch Gynecol Obstet
; 309(2): 699-706, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38099955
2.
Presence of endometrioma decreased blastocyst formation rate but not impair Assisted Reproductive Technology (ART) outcome.
Arch Gynecol Obstet
; 307(6): 2011-2020, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37067551
3.
Development of a Predictive Model for Optimization of Embryo Transfer Timing Using Blood-Based microRNA Expression Profile.
Int J Mol Sci
; 25(1)2023 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38203247
4.
Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer.
Sci Rep
; 13(1): 6741, 2023 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37185812
5.
A retrospective, matched case-control study of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol.
Front Endocrinol (Lausanne)
; 13: 931756, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36046790
6.
Corrigendum: A retrospective, matched case-control study of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol.
Front Endocrinol (Lausanne)
; 13: 1099647, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36568111
Resultados
1 -
6
de 6
1
Próxima >
>>